Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sub-committee seeks assurances for NI medicine supplies
Restrictions would primarily affect the farming industry, but also impacts show animals.
Letter to UK government calls for solution between UK and EU.

An inquiry has prompted a sub-committee to write to the UK government with concerns about Northern Ireland’s future veterinary medicine access.

The sub-committee says that, with Northern Ireland posed to lose access to currently used medicines, a swift solution between the UK and EU is needed to protect animal health.

Northern Ireland is currently in a grace period until December 2025 for veterinary medicines. However, if no solution is found, it will have to comply with full European Union regulations.

The Sub-Committee on the Windsor Framework launched its inquiry in January, examining how EU Veterinary Medicinal Products Regulation would affect Northern Ireland and its veterinary industry. It also considered the effects of no solution.

The committee spoke with a range of stakeholders, including veterinary professionals, academics and the government.

Findings revealed that, without a solution, Northern Ireland risked losing access to approximately a third of its currently used veterinary medicines after the grace period. This could not only affect companion animals, equine and farm animals, but also human health.

The restrictions would primarily affect the farming industry, making it harder for farmers to sell produce and further risking public health. Discussions found that rural economy was considered essential to Northern Ireland, so restrictions and associated costs could cause social and economic consequences.

However there were also concerns for show animals, such as horses and companion animals, that would not receive the necessary vaccinations to compete in events such as the Olympics.

The committee has asked that the government provides an updated assessment of medicines which could be discontinued, as well as an assessment on the reduction of medicines for human health and the food supply chain.

It has also called for an analysis of the potential economic consequences of this reduction in availability, and an update on the progress made in reaching a solution.

Lord Jay of Ewelme, chair of The Windsor Framework Sub-Committee, said: “We have set out some solutions proposed by our witnesses.

“They were united on the importance of political will in resolving this crucial issue, and the urgency in doing so, and we endorse their call for talks leading to a mutually-agreed solution between the UK and the EU as soon as possible.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.